Axsome Therapeutics, Inc. (AXSM) Social Stream
Axsome Therapeutics Inc (AXSM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AXSM.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 21 months, AXSM's average price target has gone down $73.55.
Over the past 48 weeks, AXSM's average upside potential has been 183.71%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
AXSM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 151 days, AXSM's average broker recommendation rating improved by 0.42.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AXSM as an investment opportunity.
- In the context of all US stocks, Axsome Therapeutics Inc's variance in analysts' estimates is lower than -391.62% of them.
- AXSM has a higher upside potential (average analyst target price relative to current price) than 441.96% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, Axsome Therapeutics Inc's number of analysts covering the stock is greater than 432.79% of them.
- In the context of Pharmaceutical Products stocks, Axsome Therapeutics Inc's average analyst price target is greater than 423.36% of them.
In the Pharmaceutical Products industry, AVIR, AUPH, and ATAI are the three stocks most similar to Axsome Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is AXSM a Buy, Hold or Sell? See the POWR Ratings now!